The Dutch Presidency makes moves to shake the medicines accessibility and affordability landscape, questioning the suitability of patents, market exclusivities and monopolies, and announcing draft Council Conclusions on medicines. By Yannis Natsis, @ynatsis Policy Coordinator, Universal access and affordable medicines, EPHA On April 18 2016, EU health ministers met in Amsterdam to discuss accessibility and … Continue reading Patents or no patents? No longer a taboo issue